InvestorsHub Logo
Followers 23
Posts 1725
Boards Moderated 0
Alias Born 09/03/2015

Re: steadyhand post# 16641

Thursday, 02/22/2018 10:48:39 AM

Thursday, February 22, 2018 10:48:39 AM

Post# of 21373
They have enough money to get through the first part of phase I. If that yields solid results, the PPS should increase at least to the .30-.50 range. That will be enough for them to get more funding without hurting investor value. They will also get non toxic funding from a foreign licensing partner. And like I've said before, since this is an orphan drug, if the results are significant after phase II, they can push for an FDA approval and completely forego phase III. You also have to remember that positive results, if they are significant enough, make a small company such as Oncolix an attractive buyout target. Then it won't matter if we get volume, a buyout is the best thing that can happen.

IMO
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.